Recce Pharmaceuticals to expand diabetes foot infection trial as results prove strong Posted on January 18, 2024September 25, 2024 by recce_com Recce Pharmaceuticals to expand diabetes foot infection trial as results prove strong
Revolutionary Antibiotic-Resistant Gonorrhea Treatment: A Possible Breakthrough with Recce 327 Posted on January 11, 2024September 25, 2024 by recce_com Revolutionary Antibiotic-Resistant Gonorrhea Treatment: A Possible Breakthrough with Recce 327
4 Biotech Executives Share Strategies Behind Successful Fund Raises Posted on January 8, 2024September 25, 2024 by recce_com 4 Biotech Executives Share Strategies Behind Successful Fund Raises
Recce Pharmaceuticals higher on positive efficacy data in Murdoch Children’s Research Institute UTI study Posted on January 8, 2024September 25, 2024 by recce_com Recce Pharmaceuticals higher on positive efficacy data in Murdoch Children’s Research Institute UTI study
Recce Pharmaceuticals — Landmark commitment helps fund R&D costs Posted on December 22, 2023September 25, 2024 by recce_com Recce Pharmaceuticals — Landmark commitment helps fund R&D costs
Recce secures Australia’s largest-ever $11m Advanced Overseas R&D Finding Posted on December 20, 2023September 25, 2024 by recce_com Recce secures Australia’s largest-ever $11m Advanced Overseas R&D Finding
Recce Pharmaceuticals awarded A$11 million Advanced Overseas Finding for anti-viral R&D costs Posted on December 17, 2023September 25, 2024 by recce_com Recce Pharmaceuticals awarded A$11 million Advanced Overseas Finding for anti-viral R&D costs
Recce Pharmaceuticals awarded $43.7 million Advanced Overseas Finding for synthetic anti-infective development program Posted on December 15, 2023September 25, 2024 by recce_com Recce Pharmaceuticals awarded $43.7 million Advanced Overseas Finding for synthetic anti-infective development program
Recce Pharmaceuticals lead anti-infective R327 shows promise against deadly STD in latest animal study Posted on December 14, 2023September 25, 2024 by recce_com Recce Pharmaceuticals lead anti-infective R327 shows promise against deadly STD in latest animal study
Antimicrobial resistance with Recce Pharmaceuticals Posted on December 6, 2023September 25, 2024 by recce_com Antimicrobial resistance with Recce Pharmaceuticals
